Biogen Inc

Iconic Profile

Biogen Inc. (BIIB) is a leading biotechnology company focused on discovering, developing, and delivering innovative therapies for neurological diseases. With a market capitalization of $29.9 billion, Biogen specializes in treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease, positioning itself as a key player in the healthcare sector. The company is recognized for its commitment to advancing science and improving patient outcomes through research and development. Biogen's robust pipeline and strategic collaborations underscore its role in addressing unmet medical needs, making it a significant entity in the biotechnology landscape. Its focus on complex neurological disorders highlights the importance of innovation in healthcare, as these conditions often lack effective treatment options.